Development and In-vitro Characterization of Fish Oil Oleogels Containing Benzoyl Peroxide and Salicylic Acid as Keratolytic Agents

Abstract

Topical keratolytic agents such as benzoyl peroxide (BP) and salicylic acid (SA) are one of the common treatments for inflammatory skin diseases. However, the amount of drug delivery through the skin is limited due to the stratum corneum. The purposes of this study were to investigate the ability of fish oil to act as penetration enhancer for topical keratolytic agents and to determine the suitable gelator for formulating stable fish oil oleogels. 2 types of gelling agents, beeswax and sorbitan monostearate (Span 60), were used to formulate oleogels. To investigate the efficacy of fish oil oleogel permeation, commercial hydrogels of benzoyl peroxide (BP) and salicylic acid (SA) were used as control, and comparative analysis was performed using Franz diffusion cell. Stability of oleogels was determined by physical assessments at 20°C and 40°C storage. Benzoyl peroxide (BP) fish oil oleogels containing beeswax were considered as better formulations in terms of drug permeation and cumulative drug release. All the results were found to be statistically significant (p<0.05, ANOVA) and it was concluded that the beeswax-fish oil combination in oleogel can prove to be beneficial in terms of permeation across the skin and stability.

Key words

fish oil - penetration enhancer - oleogel - anti-inflammatory

• References

• 1 Pasquali R, Sacco N, Bregni C. Stability of lipogels with low molecular mass gelators and emollient oils. J Disper Sci Technol 2010; 31: 482-487
• 2 Murdan S. Organogels in drug delivery. Expert Opin Drug Deliv 2005; 2: 489-505
• 3 Chen H, Khemtong C, Yang X et al. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today 2011; 16: 354-360
• 4 Sahoo S, Kumar N, Bhattacharya C et al. Organogels: properties and applications in drug delivery. Des Monomers Polym 2011; 14: 95-108
• 5 Zulfakar MH, Abdeoluahab N, Heard CM. Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil. Inflam Res 2010; 59: 23-30
• 6 Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother 2002; 56: 386-396
• 7 Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 2010; 21: 781-792
• 8 Fetterman JWJ, Zdanowicz M. Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health syst Pharm 2009; 66: 1169-1179
• 9 Soyland E, Funk J, Rajka G et al. Effect of dietary supplementation with very-long chain n-3 fatty acids in patients with psoriasis. New Engl J Med 1993; 328: 1812-1816
• 10 Mayser P, Mrowietz U, Arenberger P et al. omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: Results of a double blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998; 38: 539-547
• 11 Heard CM, Gallagher SJ, Harwood J et al. The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle – evidence that solute permeate skin association with their salvation cages?. Int J Pharm 2003; 261
• 12 Thomas CP, Heard CM. Probing the skin permeation of eicosapentaenoic acid and ketoprofen: 2. comparative depth profiling and metabolism of eicosapentaenoic acid. Eur J Pharm Biopharm 2007; 67: 156-165
• 13 Puglia C, Tropea S, Rizza L et al. In vitro percutaneous absorption studies and in vivo evaluation of anti-inflammatory activity of essential fatty acids (EFA) from fish oil extracts. Int J Pharm 2005; 299: 41-48
• 14 Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol 2010; 63: 52-62
• 15 Kraft J, Freiman A. Management of acne. CMAJ 2011; 183: 430-435
• 16 Tsai JC, Chuang SA, Hsu MY et al. Distribution of salicylic acid in human stratum corneum following topical application in vivo: a comparison of six different formulations. Int J Pharm 1999; 188: 145-153
• 17 Waller JM, Dreher F, Behnam S et al. Keratolytic properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol 2006; 19: 283-289
• 18 Hatakeyama S, Hayashi S, Yoshida Y et al. Retionic acid disintegrated desmosomes and hemidesmosomes in stratified oral keratinocytes. J Oral Pathol Med 2004; 33: 622-628
• 19 Zulfakar MH, Edwards M, Heard CM. Is there a role for topically delivered eicosapentaenoic acid in the treatment of psoriasis?. Eur J Dermatol 2007; 17: 284-291
• 20 Murdan S, Gregoriadis G, Florence AT. Inverse toroidal vesicles: precursors of tubules in sorbitan monostearate organogels. Int J Pharm 1999; 183: 47-49
• 21 Almedia IF, Bahia MF. Evaluation of the physical stability of two oleogels. Int J Pharm 2006; 327: 73-77
• 22 Attama AA, Schicke BC, Muller-Goymann CC. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems. Eur J Pharm Biopharm 2006; 64: 294-306
• 23 Ofner Iii CM, Klech-Gellote CM. Encyclopedia of Pharmaceutical Technology. New York: Informa Healthcare;
• 24 Florence AT, Attwood D. Physiochemical Principles of Pharmacy. London: Macmillan Press Ltd;
• 25 Yosipovitch G, Maibach HI. Skin surface pH: a protective acid mantle. Cosmet Toiletries 1996; 111: 101-102
• 26 Zhai H, Chan HP, Farahmand S et al. Measuring human skin buffering capacity: an in vitro model. Skin Res Technol 2009; 15: 470-475
• 27 Thomas CP, Heard CM. In vitro transcutaneous delivery of ketoprofen and essential polyunsaturated fatty acids from a fish oil vehicle incorporating 1, 8-Cineole. Drug Deliv 2004; 12: 7-14
• 28 Saarinen SP, Jarvinen T, Taipale H et al. Method for evaluating drug release from liposomes in sink conditions. Int J Pharm 1997; 159: 27-33
• 29 Valencia IC, Kerdel FA. Fitzpatrick’s Dermatology in General Medicine. New York: McGraw Hill; 2003
• 30 Wang MY, Yang YY, Paul HWS. Role of solvent in interactions between fatty acids-based formulation and lipids in porcine stratum corneum. J Control Release 2004; 94: 207-216
• 31 Shelton RM. Aloe Vera: its chemical and therapeutic properties. Int J Dermatol 1991; 30: 670-683
• 32 Barry BW. Novel mechanism and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14: 101-114
• 33 Dal’belo SE, Gaspar LR, Maia CPM. Moisturizing effect of cosmetic formulation containing Aloe vera extract in different concentration assessed by skin bioengineering techniques. Skin Res Technol 2006; 12: 241-246